Singapore: Ministry of Health proposing amendments to Healthcare Services Act to enhance patient safety

In brief

To strengthen the safeguards for patient safety and welfare, the Singapore Ministry of Health (MOH) has proposed several amendments to the Healthcare Services Act (HCSA). The proposed amendments are targeted for implementation in June 2023.

The public is invited to share their views and provide feedback on the proposed changes to the HCSA from 12 October to 11 November 2022.


In more detail



The Healthcare Services Bill was passed in the Singapore Parliament in 2020 to progressively replace the Private Hospitals and Medical Clinics Act (PHMCA). The HCSA was intended to better safeguard patient safety and well-being while allowing the MOH to adopt a more flexible approach in regulating and catering to the ever-changing healthcare landscape.

The regulatory regime under the HCSA is a services-based licensing regime, where healthcare service providers are/will be licensed based on the healthcare service provided, as opposed to the previous regulatory regime under the PHMCA, which was a premises-based licensing regime.

There are three phases to the implementation of the HSCA, with Phase 1 having come into effect in January 2022; and Phase 2 and Phase 3 coming into effect in June 2023 and by the end of 2023 respectively.

Proposed amendments to the HCSA

To enhance the robustness of the regulatory regime under the HCSA, and, in particular, to strengthen safeguards for patient safety and welfare, the MOH has proposed the following changes to the HCSA:

1, Advertising restrictions

  • When advertising, businesses that have not obtained licences under the HCSA for their healthcare services cannot claim to treat medical conditions or diseases.
  • Non-registered healthcare professionals who use the title "Dr" in their advertisements must state clearly their qualifications and credentials to avoid misleading the public into thinking that the "Dr" is associated with the general medical practice.

2. Restrictions on the use of specialty names in business names

  • Businesses licensed under the HCSA are prohibited from using terms associated with specialties in their business names if they do not employ such specialists.

3. Regulation of different modes of healthcare service delivery

  • Given the different channels through which healthcare services may be provided, the MOH will introduce different modes of healthcare service delivery. For instance, a medical clinic can opt for "Permanent Premises" for providing healthcare services at brick-and-mortar physical premises; "Temporary Premises" for providing healthcare services via home visits or community site screenings; and "Remote" for teleconsultations.

4. Approval regime for specified services and appointment of clinical governance officers

  • An approval regime would be introduced for certain specified services, which include the provision of imaging modalities such as ultrasounds and X-rays.
  • "Clinical governance officers" are one of the four key officeholders under the HCSA, who mainly assist the licensee in clinical governance and technical oversight of complex services.

5. Refining the scope of employee background screening according to the degree of risk to patient safety and welfare

6. Removal of the 14-day notice requirement prior to modification of licensee conditions in certain circumstances

  • Under the current HCSA, the MOH must give notice to the licensee before modifying conditions of its licence, and must allow the licensee at least 14 days after the date when the noticed is served to make written representations regarding the proposed modification.
  • By removing the 14-day notice period, it allows the MOH to take immediate action to address urgent patient safety issues in certain special circumstances. For example, the MOH can require licensees to implement screening requirements for patients to mitigate the spread of infectious diseases like COVID-19.

The proposed amendments are targeted to be implemented in June 2023. The MOH is now seeking feedback from existing licensees, potential licensees and the general public on the proposed amendments above.

From 12 October to 11 November 2022, members of the public can visit the HCSA website to provide feedback.

* * * * *


© 2022 Baker & McKenzie.Wong & Leow. All rights reserved. Baker & McKenzie.Wong & Leow is incorporated with limited liability and is a member firm of Baker & McKenzie International, a global law firm with member law firms around the world. In accordance with the common terminology used in professional service organizations, reference to a "principal" means a person who is a partner, or equivalent, in such a law firm. Similarly, reference to an "office" means an office of any such law firm. This may qualify as "Attorney Advertising" requiring notice in some jurisdictions. Prior results do not guarantee a similar outcome.

Contact Information

Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.